Sage Therapeutics Announces Second Quarter 2019 Financial Results and Highlights Pipeline and Business Progress Odessa AmericanToday, Sage Therapeutics (NASDAQ: SAGE), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of ...